Chapter/Section Purchase

1 Study Coverage
1.1 Osteoarthritis Pain Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Osteoarthritis Pain Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Osteoarthritis Pain Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Osteoarthritis Pain Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Osteoarthritis Pain Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Osteoarthritis Pain Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Osteoarthritis Pain Drugs Sales by Region
2.4.1 Global Osteoarthritis Pain Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Osteoarthritis Pain Drugs by Region (2023-2028)
2.5 Global Osteoarthritis Pain Drugs Revenue by Region
2.5.1 Global Osteoarthritis Pain Drugs Revenue by Region (2017-2022)
2.5.2 Global Osteoarthritis Pain Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Osteoarthritis Pain Drugs Sales by Manufacturers
3.1.1 Global Top Osteoarthritis Pain Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Osteoarthritis Pain Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Osteoarthritis Pain Drugs in 2021
3.2 Global Osteoarthritis Pain Drugs Revenue by Manufacturers
3.2.1 Global Osteoarthritis Pain Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Osteoarthritis Pain Drugs Revenue in 2021
3.3 Global Osteoarthritis Pain Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Osteoarthritis Pain Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Osteoarthritis Pain Drugs Sales by Type
4.1.1 Global Osteoarthritis Pain Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Osteoarthritis Pain Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Osteoarthritis Pain Drugs Sales Market Share by Type (2017-2028)
4.2 Global Osteoarthritis Pain Drugs Revenue by Type
4.2.1 Global Osteoarthritis Pain Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Osteoarthritis Pain Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Osteoarthritis Pain Drugs Price by Type
4.3.1 Global Osteoarthritis Pain Drugs Price by Type (2017-2022)
4.3.2 Global Osteoarthritis Pain Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Osteoarthritis Pain Drugs Sales by Application
5.1.1 Global Osteoarthritis Pain Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Osteoarthritis Pain Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Osteoarthritis Pain Drugs Sales Market Share by Application (2017-2028)
5.2 Global Osteoarthritis Pain Drugs Revenue by Application
5.2.1 Global Osteoarthritis Pain Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Osteoarthritis Pain Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Osteoarthritis Pain Drugs Price by Application
5.3.1 Global Osteoarthritis Pain Drugs Price by Application (2017-2022)
5.3.2 Global Osteoarthritis Pain Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Osteoarthritis Pain Drugs Market Size by Type
6.1.1 North America Osteoarthritis Pain Drugs Sales by Type (2017-2028)
6.1.2 North America Osteoarthritis Pain Drugs Revenue by Type (2017-2028)
6.2 North America Osteoarthritis Pain Drugs Market Size by Application
6.2.1 North America Osteoarthritis Pain Drugs Sales by Application (2017-2028)
6.2.2 North America Osteoarthritis Pain Drugs Revenue by Application (2017-2028)
6.3 North America Osteoarthritis Pain Drugs Market Size by Country
6.3.1 North America Osteoarthritis Pain Drugs Sales by Country (2017-2028)
6.3.2 North America Osteoarthritis Pain Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Osteoarthritis Pain Drugs Market Size by Type
7.1.1 Europe Osteoarthritis Pain Drugs Sales by Type (2017-2028)
7.1.2 Europe Osteoarthritis Pain Drugs Revenue by Type (2017-2028)
7.2 Europe Osteoarthritis Pain Drugs Market Size by Application
7.2.1 Europe Osteoarthritis Pain Drugs Sales by Application (2017-2028)
7.2.2 Europe Osteoarthritis Pain Drugs Revenue by Application (2017-2028)
7.3 Europe Osteoarthritis Pain Drugs Market Size by Country
7.3.1 Europe Osteoarthritis Pain Drugs Sales by Country (2017-2028)
7.3.2 Europe Osteoarthritis Pain Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Osteoarthritis Pain Drugs Market Size by Type
8.1.1 Asia Pacific Osteoarthritis Pain Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Osteoarthritis Pain Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Osteoarthritis Pain Drugs Market Size by Application
8.2.1 Asia Pacific Osteoarthritis Pain Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Osteoarthritis Pain Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Osteoarthritis Pain Drugs Market Size by Region
8.3.1 Asia Pacific Osteoarthritis Pain Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Osteoarthritis Pain Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Osteoarthritis Pain Drugs Market Size by Type
9.1.1 Latin America Osteoarthritis Pain Drugs Sales by Type (2017-2028)
9.1.2 Latin America Osteoarthritis Pain Drugs Revenue by Type (2017-2028)
9.2 Latin America Osteoarthritis Pain Drugs Market Size by Application
9.2.1 Latin America Osteoarthritis Pain Drugs Sales by Application (2017-2028)
9.2.2 Latin America Osteoarthritis Pain Drugs Revenue by Application (2017-2028)
9.3 Latin America Osteoarthritis Pain Drugs Market Size by Country
9.3.1 Latin America Osteoarthritis Pain Drugs Sales by Country (2017-2028)
9.3.2 Latin America Osteoarthritis Pain Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Osteoarthritis Pain Drugs Market Size by Type
10.1.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Osteoarthritis Pain Drugs Market Size by Application
10.2.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Osteoarthritis Pain Drugs Market Size by Country
10.3.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Overview
11.2.3 Bayer Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayer Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 SK Chemicals
11.3.1 SK Chemicals Corporation Information
11.3.2 SK Chemicals Overview
11.3.3 SK Chemicals Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 SK Chemicals Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 SK Chemicals Recent Developments
11.4 GSK
11.4.1 GSK Corporation Information
11.4.2 GSK Overview
11.4.3 GSK Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GSK Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GSK Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sanofi Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Crystal Genomics
11.6.1 Crystal Genomics Corporation Information
11.6.2 Crystal Genomics Overview
11.6.3 Crystal Genomics Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Crystal Genomics Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Crystal Genomics Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Overview
11.7.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Johnson & Johnson Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnson & Johnson Recent Developments
11.8 Sino Biopharmaceutical
11.8.1 Sino Biopharmaceutical Corporation Information
11.8.2 Sino Biopharmaceutical Overview
11.8.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sino Biopharmaceutical Recent Developments
11.9 Haohai Biological
11.9.1 Haohai Biological Corporation Information
11.9.2 Haohai Biological Overview
11.9.3 Haohai Biological Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Haohai Biological Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Haohai Biological Recent Developments
11.10 Zhejiang Chengyi Pharmaceutical
11.10.1 Zhejiang Chengyi Pharmaceutical Corporation Information
11.10.2 Zhejiang Chengyi Pharmaceutical Overview
11.10.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zhejiang Chengyi Pharmaceutical Recent Developments
11.11 Freda
11.11.1 Freda Corporation Information
11.11.2 Freda Overview
11.11.3 Freda Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Freda Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Freda Recent Developments
11.12 Bright Future
11.12.1 Bright Future Corporation Information
11.12.2 Bright Future Overview
11.12.3 Bright Future Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Bright Future Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Bright Future Recent Developments
11.13 Jingfeng Pharmaceutical
11.13.1 Jingfeng Pharmaceutical Corporation Information
11.13.2 Jingfeng Pharmaceutical Overview
11.13.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Jingfeng Pharmaceutical Recent Developments
11.14 Chugai Pharmaceutical
11.14.1 Chugai Pharmaceutical Corporation Information
11.14.2 Chugai Pharmaceutical Overview
11.14.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Chugai Pharmaceutical Recent Developments
11.15 Mikasa Seiyaku
11.15.1 Mikasa Seiyaku Corporation Information
11.15.2 Mikasa Seiyaku Overview
11.15.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Mikasa Seiyaku Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Mikasa Seiyaku Recent Developments
11.16 Taisho Pharmaceutical
11.16.1 Taisho Pharmaceutical Corporation Information
11.16.2 Taisho Pharmaceutical Overview
11.16.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Taisho Pharmaceutical Recent Developments
11.17 Seikagaku Corporation
11.17.1 Seikagaku Corporation Corporation Information
11.17.2 Seikagaku Corporation Overview
11.17.3 Seikagaku Corporation Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Seikagaku Corporation Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Seikagaku Corporation Recent Developments
11.18 GlaxoSmithKline
11.18.1 GlaxoSmithKline Corporation Information
11.18.2 GlaxoSmithKline Overview
11.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 GlaxoSmithKline Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 GlaxoSmithKline Recent Developments
11.19 Eli Lilly
11.19.1 Eli Lilly Corporation Information
11.19.2 Eli Lilly Overview
11.19.3 Eli Lilly Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Eli Lilly Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Eli Lilly Recent Developments
11.20 Novartis
11.20.1 Novartis Corporation Information
11.20.2 Novartis Overview
11.20.3 Novartis Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Novartis Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Novartis Recent Developments
11.21 Horizon Pharma
11.21.1 Horizon Pharma Corporation Information
11.21.2 Horizon Pharma Overview
11.21.3 Horizon Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Horizon Pharma Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Horizon Pharma Recent Developments
11.22 Abbott
11.22.1 Abbott Corporation Information
11.22.2 Abbott Overview
11.22.3 Abbott Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Abbott Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Abbott Recent Developments
11.23 Mylan
11.23.1 Mylan Corporation Information
11.23.2 Mylan Overview
11.23.3 Mylan Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Mylan Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Mylan Recent Developments
11.24 Daiichi Sankyo
11.24.1 Daiichi Sankyo Corporation Information
11.24.2 Daiichi Sankyo Overview
11.24.3 Daiichi Sankyo Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Daiichi Sankyo Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Daiichi Sankyo Recent Developments
11.25 TEVA
11.25.1 TEVA Corporation Information
11.25.2 TEVA Overview
11.25.3 TEVA Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.25.4 TEVA Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 TEVA Recent Developments
11.26 Almatica Pharma
11.26.1 Almatica Pharma Corporation Information
11.26.2 Almatica Pharma Overview
11.26.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.26.4 Almatica Pharma Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 Almatica Pharma Recent Developments
11.27 Astellas Pharma
11.27.1 Astellas Pharma Corporation Information
11.27.2 Astellas Pharma Overview
11.27.3 Astellas Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.27.4 Astellas Pharma Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.27.5 Astellas Pharma Recent Developments
11.28 Tide Pharmaceutical
11.28.1 Tide Pharmaceutical Corporation Information
11.28.2 Tide Pharmaceutical Overview
11.28.3 Tide Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.28.4 Tide Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.28.5 Tide Pharmaceutical Recent Developments
11.29 Iroko Pharmaceuticals
11.29.1 Iroko Pharmaceuticals Corporation Information
11.29.2 Iroko Pharmaceuticals Overview
11.29.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.29.4 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.29.5 Iroko Pharmaceuticals Recent Developments
11.30 Hengrui Pharmaceutical
11.30.1 Hengrui Pharmaceutical Corporation Information
11.30.2 Hengrui Pharmaceutical Overview
11.30.3 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.30.4 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.30.5 Hengrui Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Osteoarthritis Pain Drugs Industry Chain Analysis
12.2 Osteoarthritis Pain Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Osteoarthritis Pain Drugs Production Mode & Process
12.4 Osteoarthritis Pain Drugs Sales and Marketing
12.4.1 Osteoarthritis Pain Drugs Sales Channels
12.4.2 Osteoarthritis Pain Drugs Distributors
12.5 Osteoarthritis Pain Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Osteoarthritis Pain Drugs Industry Trends
13.2 Osteoarthritis Pain Drugs Market Drivers
13.3 Osteoarthritis Pain Drugs Market Challenges
13.4 Osteoarthritis Pain Drugs Market Restraints
14 Key Findings in The Global Osteoarthritis Pain Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer